INM-755 was found to be safe in five adults with epidermolysis bullosa (EB) who were treated with the…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Two new mutations in the COL7A1 gene, one inherited from each parent, were identified as the cause of recessive…
Researchers have identified three cases of epidermolysis bullosa acquisita (EBA) in children, which they described in a…
A gene-edited skin cell therapy — called Spray-On Skin cells — promotes skin healing by correcting the mutation associated with…